UK markets closed

Edesa Biotech, Inc. (EDSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.6100+0.0600 (+1.32%)
At close: 04:00PM EDT
4.6600 +0.05 (+1.08%)
After hours: 04:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
328.801
Cost of revenue
-
-
-
0
17.601
Gross profit
-
-
-
0
311.2
Operating expenses
Research development
4,142
4,795
13,335
17,947
3,329
Selling general and administrative
4,560
4,428
5,035
5,734
3,383
Total operating expenses
8,000
8,642
17,591
13,340
6,712
Operating income or loss
-8,000
-8,642
-17,591
-13,340
-6,401
Total other income/expenses net
-18.623
-21.742
-21.114
-13.022
-0.366
Income before tax
-7,717
-8,374
-17,548
-13,342
-6,363
Income tax expense
-
0.8
0.8
0.8
0.8
Income from continuing operations
-7,718
-8,374
-17,549
-13,343
-6,364
Net income
-7,718
-8,374
-17,549
-13,343
-6,364
Net income available to common shareholders
-7,718
-8,374
-17,549
-13,343
-6,364
Basic EPS
-20.51
-20.51
-8.37
-7.70
-5.18
Diluted EPS
-20.51
-20.51
-8.37
-7.70
-5.18
Basic average shares
408.418
408.418
2,096
1,725
1,230
Diluted average shares
408.418
408.418
2,096
1,725
1,230